RecruitingPhase 3NCT07037433
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Sponsor: Amgen
Amarillo, TX · Austin, TX · +137 more sites
4 recruiting obesity studies with a site in Kingwood, TX.
Sponsor: Amgen
Amarillo, TX · Austin, TX · +137 more sites
Sponsor: Eli Lilly and Company
Cypress, TX · Houston, TX · Kingwood, TX · +27 more sites
Sponsor: Eli Lilly and Company
Austin, TX · Brownsville, TX · Dallas, TX · +77 more sites
Sponsor: Eli Lilly and Company
Bellaire, TX · Dallas, TX · +52 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.